PAPA NONOate
Based on 2 publication(s) in Google Scholar
PAPA NONOate is a NO donor with a NO release half-life of 77 min (22-25°C). PAPA NONOate may represent a potential research for impaired wound healing in diabetes by increasing the rate of collagen synthesis at the wound site.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 146672-58-4
- Formula: C6H16N4O2
- Molecular Weight:176.22
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) PAPA NONOate
MoreAll Endogenous Metabolite Isoforms
More
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Anesthetized male Sprague-Dawley rats with streptozotocin-induced diabetes and full thickness dermal wound[2]
-
Dosage:100 μM
-
Administration:Wounds received 100 μM PAPA NONOate in phosphate buffer
-
Result:Increased the wound healing rate in test group.
Chemical Information
-
CAS No. 146672-58-4
-
Appearance Solid
-
Molecular Weight 176.22
-
Formula C6H16N4O2
-
Color White to light yellow
-
SMILES
NCCCN(CCC)N(O)N=O
-
Structure Classification
-
Initial Source
-
Shipping
Shipping with dry ice.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
ACS Nano
Triple-Cascade Responsive Pneumatic Nanomotor Enhance Cancer Immunotherapy by Oncolytic Virus-Triggered Pyroptosis. [Abstract]2026 Mar 31;20(12):9784-9801. PMID: 41842752 -
Neurosci Bull
2025 Jun 28. PMID: 40580390
Solvent & Solubility
H2O : 50 mg/mL (283.74 mM; ultrasonic and warming and heat to 60°C)
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Rössig L, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem. 1999 Mar 12;274(11):6823-6. [Content Brief]
[3]. Keefer LK, et al. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 1996;268:281-93. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 5.6747 mL | 28.3736 mL | 56.7472 mL | 141.8681 mL |
| 5 mM | 1.1349 mL | 5.6747 mL | 11.3494 mL | 28.3736 mL | |
| 10 mM | 0.5675 mL | 2.8374 mL | 5.6747 mL | 14.1868 mL | |
| 15 mM | 0.3783 mL | 1.8916 mL | 3.7831 mL | 9.4579 mL | |
| 20 mM | 0.2837 mL | 1.4187 mL | 2.8374 mL | 7.0934 mL | |
| 25 mM | 0.2270 mL | 1.1349 mL | 2.2699 mL | 5.6747 mL | |
| 30 mM | 0.1892 mL | 0.9458 mL | 1.8916 mL | 4.7289 mL | |
| 40 mM | 0.1419 mL | 0.7093 mL | 1.4187 mL | 3.5467 mL | |
| 50 mM | 0.1135 mL | 0.5675 mL | 1.1349 mL | 2.8374 mL | |
| 60 mM | 0.0946 mL | 0.4729 mL | 0.9458 mL | 2.3645 mL | |
| 80 mM | 0.0709 mL | 0.3547 mL | 0.7093 mL | 1.7734 mL | |
| 100 mM | 0.0567 mL | 0.2837 mL | 0.5675 mL | 1.4187 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.